real-world data

Open Access
Evaluation of Five-year Overall Survival Rates Among 18,331 Head and Neck Cancer Patients Exposed to Different Targeted Therapies Through Real-world Data in a Case-controlled Study
JOSEFINE BAUDREXL, ANDREAS SAKKAS, SEBASTIAN PIETZKA, SPYRIDOULA DERKA, GEORGIA VAIRAKTARI, MARIO SCHEURER, ALEXANDER SCHRAMM, FRANK WILDE and MARCEL EBELING

Anticancer Research March 2024, 44 (3) 1247-1270; DOI: https://doi.org/10.21873/anticanres.16921
You have access
Sex-specific Real-World 5-year Overall Survival Rates for (Radio)chemotherapy, Targeted Therapy, and Combinations in Patients With Head and Neck Cancer
JOSEFINE BAUDREXL, SEBASTIAN PIETZKA, MARIO SCHEURER, ALEXANDER SCHRAMM, FRANK WILDE, ANDREAS SAKKAS, SPYRIDOULA DERKA and MARCEL EBELING

Anticancer Research January 2024, 44 (1) 267-286; DOI: https://doi.org/10.21873/anticanres.16810
You have access
Angiotensin II Receptor Blockers Cause Changes in Prostate-specific Antigen Levels: A Retrospective Cohort Study
AYAKO MAEDA-MINAMI, TOMOKI NISHIKAWA, HIDEKI ISHIKAWA, MICHIHIRO MUTOH, YOSHITO MAKISHIMA, YUTAKA MATSUYAMA, KAZUNORI AKIMOTO, YASUNARI MANO and HIROJI UEMURA

Anticancer Research December 2023, 43 (12) 5629-5636; DOI: https://doi.org/10.21873/anticanres.16766
You have access
Real-world Data and Economic Evaluation of Nivolumab in Previously Treated Non-small Cell Lung Cancer Greek Patients
HELENA LINARDOU, SOFIA LAMPAKI, GEORGIA-ANGELIKI KOLIOU, ATHANASSIOS VOZIKIS, ANASTASIOS BOUTIS, ADAMANTIA NIKOLAIDI, IOANNIS KONTOGIORGOS, PAVLOS PAPAKOTOULAS, ATHINA CHRISTOPOULOU, DIONYSIOS SPYRATOS, DIMITRIOS BAFALOUKOS, AMANDA PSYRRI, ANASTASIOS GRIVAS, ANNA KOUMARIANOU, KARYOFYLLIS TSIAKITZIS, DAVIDE MAURI, GEORGIOS RIGAKOS, GERASIMOS ARAVANTINOS, PANAGIOTIS PAPANTONIOU, GEORGIOS OIKONOMOPOULOS, ELENA FOUNTZILAS, MARGARITA-IOANNA KOUFAKI, MARIA KAPARELOU, ELIAS LIOLIS, GIANNIS MOUNTZIOS, PARIS KOSMIDIS, GEORGE FOUNTZILAS and EPAMINONDAS SAMANTAS

Anticancer Research June 2023, 43 (6) 2799-2812; DOI: https://doi.org/10.21873/anticanres.16449
Open Access
Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer
SANDRO M. WAGNER, TERESA MAGNES, THOMAS MELCHARDT, DOMINIK KIEM, LUKAS WEISS, DANIEL NEUREITER, CHRISTINA WAGNER, MARIE-BERNADETTE ARETIN, STEFAN NEMEC, GABRIELE GAMERITH, GEORG PALL, RICHARD GREIL and THORSTEN FUEREDER

Anticancer Research March 2023, 43 (3) 1273-1282; DOI: https://doi.org/10.21873/anticanres.16274
You have access
Comparison of Chemotherapeutic Regimens Frequently Used in Metastatic Non-squamous NSCLC Treatment
DANIEL KREJCI, PETR OPALKA, JANA KREJCI, MILADA ZEMANOVA, PETRA ZEMANOVA, JURAJ KULTAN, ONDREJ FISCHER, JANA SKRICKOVA, MONIKA BRATOVA, MARKETA CERNOVSKA, MICHAL HRNCIARIK, HELENA COUPKOVA, KAROLINA HURDALKOVA, MAGDA BARINOVA, LEONA KOUBKOVA, DANIEL DOLEZAL, MARTIN SAFANDA, MILOS PESEK and MARTIN SVATON

Anticancer Research May 2021, 41 (5) 2597-2603; DOI: https://doi.org/10.21873/anticanres.15039
You have access
Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC Study
PIERRE HEUDEL, SUZETTE DELALOGE, DAMIEN PARENT, NICOLAS MADRANGES, CHRISTELLE LEVY, FLORENCE DALENC, ETIENNE BRAIN, LIONEL UWER, VERONIQUE D'HONDT, PAULE AUGEREAU, AUDREY MAILLIEZ, CHRISTOPHE PERRIN, JEAN-SEBASTIEN FRENEL, MARIE-PAULE SABLIN, MARIE-ANGE MOURET-REYNIER, THOMAS VERMEULIN, JEAN-CHRISTOPHE EYMARD, THIERRY PETIT, JEAN-MARC FERRERO, SILVIA ILIE, ANTHONY GONCALVES, GAËLLE CHENUC, MATHIEU ROBAIN, GAËTANE SIMON and DAVID PEROL

Anticancer Research July 2020, 40 (7) 3905-3913; DOI: https://doi.org/10.21873/anticanres.14381
You have access
Long-term Survival of Stage IV Melanoma Patients Treated with BOLD Combination Chemotherapy and Intermediate-dose Subcutaneous Interferon-alpha
KALLE MATTILA, PIRITA RAANTA, VALTTERI LAHTELA, SEPPO PYRHÖNEN, ILKKA KOSKIVUO and PIA VIHINEN

Anticancer Research November 2018, 38 (11) 6393-6397; DOI: https://doi.org/10.21873/anticanres.12999

Main menu

User menu

Search

real-world data